These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 28843824)
1. Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI). Königsbrügge O; Lorenz M; Auinger M; Schmaldienst S; Klauser-Braun R; Kletzmayr J; Grilz E; Posch F; Antlanger M; Pabinger I; Säemann M; Ay C Thromb Res; 2017 Oct; 158():59-64. PubMed ID: 28843824 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI). Königsbrügge O; Posch F; Antlanger M; Kovarik J; Klauser-Braun R; Kletzmayr J; Schmaldienst S; Auinger M; Zuntner G; Lorenz M; Grilz E; Stampfel G; Steiner S; Pabinger I; Säemann M; Ay C PLoS One; 2017; 12(1):e0169400. PubMed ID: 28052124 [TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation linked to vascular access thrombosis in chronic hemodialysis patients. Chou CY; Chen JY; Liu JH; Liu YL; Lin HH; Yang YF; Wang SM; Kuo HL; Huang CC J Atheroscler Thromb; 2011; 18(6):448-53. PubMed ID: 21368450 [TBL] [Abstract][Full Text] [Related]
4. Central venous catheter-related venous thrombosis in children with end-stage renal disease undergoing hemodialysis. Mandel-Shorer N; Tzvi-Behr S; Harvey E; Revel-Vilk S Thromb Res; 2018 Dec; 172():150-157. PubMed ID: 30414505 [TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Genovesi S; Pogliani D; Faini A; Valsecchi MG; Riva A; Stefani F; Acquistapace I; Stella A; Bonforte G; DeVecchi A; DeCristofaro V; Buccianti G; Vincenti A Am J Kidney Dis; 2005 Nov; 46(5):897-902. PubMed ID: 16253730 [TBL] [Abstract][Full Text] [Related]
7. Differences in Initial Hemodialysis Vascular Access Use Among Glomerulonephritis Subtypes in the United States. O'Shaughnessy MM; Montez-Rath ME; Zheng Y; Lafayette RA; Winkelmayer WC Am J Kidney Dis; 2016 Apr; 67(4):638-47. PubMed ID: 26774466 [TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension. Genovesi S; Fabbrini P; Pieruzzi F; Galbiati E; Sironi E; Pogliani D; Bonforte G; Viganò MR; Stella A J Nephrol; 2015 Oct; 28(5):615-21. PubMed ID: 25119455 [TBL] [Abstract][Full Text] [Related]
9. Exhausting multiple hemodialysis access failures. Bolleke E; Seferi S; Rroji M; Idrizi A; Barbullushi M; Thereska N Med Arch; 2014 Oct; 68(5):361-3. PubMed ID: 25568574 [TBL] [Abstract][Full Text] [Related]
11. Intensive Hemodialysis and Potential Risks With Increasing Treatment. Kraus MA; Kansal S; Copland M; Komenda P; Weinhandl ED; Bakris GL; Chan CT; Fluck RJ; Burkart JM Am J Kidney Dis; 2016 Nov; 68(5S1):S51-S58. PubMed ID: 27772644 [TBL] [Abstract][Full Text] [Related]
12. Patterns of vascular access device use and thrombosis outcomes in patients with COVID-19: a pilot multi-site study of Michigan hospitals. Sebolt J; Buchinger J; Govindan S; Zhang Q; O'Malley M; Chopra V J Thromb Thrombolysis; 2022 Feb; 53(2):257-263. PubMed ID: 34550496 [TBL] [Abstract][Full Text] [Related]
13. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313 [TBL] [Abstract][Full Text] [Related]
14. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS). Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981 [TBL] [Abstract][Full Text] [Related]
15. Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis. Shafi ST; Gupta M J Vasc Access; 2007; 8(2):103-8. PubMed ID: 17534796 [TBL] [Abstract][Full Text] [Related]
16. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter. Yu A; Egberg N; Jacobson SH Scand J Clin Lab Invest; 2003; 63(2):127-33. PubMed ID: 12751694 [TBL] [Abstract][Full Text] [Related]
18. Hospitalization for initiation of maintenance hemodialysis. Agraharkar M; Martinez MA; Kuo YF; Ahuja TS Nephron Clin Pract; 2004; 97(2):c54-60. PubMed ID: 15230279 [TBL] [Abstract][Full Text] [Related]
19. The association between pulse pressure and vascular access thrombosis in chronic hemodialysis patients. Chou CY; Liu JH; Kuo HL; Liu YL; Lin HH; Yang YF; Wang SM; Huang CC Hypertens Res; 2009 Aug; 32(8):712-5. PubMed ID: 19590503 [TBL] [Abstract][Full Text] [Related]
20. Incidence and Risk Factors of Sudden Cardiac Death in End-Stage Renal Disease Patients Undergoing Hemodialysis: A Retrospective Study. Khan MT; Hameed B; Ahmed J Saudi J Kidney Dis Transpl; 2021; 32(4):957-966. PubMed ID: 35229792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]